X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-09-15 | NTHI | Neonc Technologies Holdings, Inc. | Garnett Keithly | CFO | S - Sale | $3.36 | -5,000 | 281,410 | -2% | -$16,809 | ||||||
| M | 2026-09-17 | HTFL | Heartflow, Inc. | Verghese Vikram | CFO | S - Sale | $50.55 | -24,345 | 155,183 | -14% | -$1,230,742 | |||||
2026-09-18 | MHK | Mohawk Industries Inc | Helen Suzanne L | Possible member of group | S - Sale | $125.62 | -800 | 146,978 | -1% | -$100,496 | ||||||
| D | 2026-09-16 | ADPT | Adaptive Biotechnologies Corp | Lo Francis | Chief People Officer | S - Sale+OE | $28.06 | -115,406 | 223,367 | -34% | -$3,238,004 | |||||
2026-09-16 | CORT | Corcept Therapeutics Inc | Vieira Roberto Wandenkolk | Pres, Oncology | S - Sale | $100.82 | -296 | 3,946 | -7% | -$29,843 | ||||||
| A | 2026-09-09 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale | $18.46 | -35,994 | 88,033 | -29% | -$664,550 | |||||
2026-09-17 | BRID | Bridgford Foods Corp | Bridgford Allan Jr. | Consultant | P - Purchase | $5.80 | +1,000 | 50,000 | +2% | +$5,800 | ||||||
2026-09-16 | BE | Bloom Energy Corp | Joshi Aman | Chief Commercial Officer | S - Sale | $269.94 | -3,601 | 155,529 | -2% | -$972,054 | ||||||
2026-09-16 | BE | Bloom Energy Corp | Kurzymski Maciej | Chief Accounting Officer | S - Sale | $268.42 | -2,295 | 77,391 | -3% | -$616,024 | ||||||
2026-09-16 | SKYE | Skye Bioscience, Inc. | Schwab Andrew J. | Dir, 10% | S - Sale | $1.91 | -33,892 | 1,129,348 | -3% | -$64,734 | ||||||
2026-09-16 | SKYE | Skye Bioscience, Inc. | 5Am Partners Vii, LLC | 10% | S - Sale | $1.91 | -33,892 | 1,129,348 | -3% | -$64,734 | ||||||
2026-09-16 | BE | Bloom Energy Corp | Soderberg Shawn Marie | See Remarks | S - Sale | $270.07 | -2,870 | 468,231 | -1% | -$775,101 | ||||||
2026-09-16 | BE | Bloom Energy Corp | Chitoori Satish | Chief Operations Officer | S - Sale | $270.06 | -2,870 | 202,494 | -1% | -$775,072 | ||||||
2026-09-15 | CV | Capsovision, Inc | Shen Ching Hang | 10% | P - Purchase | $5.69 | +878,734 | 2,926,655 | +43% | +$4,999,996 | ||||||
2026-09-18 | SYNA | Synaptics Inc | Bodensteiner Lisa | See Remarks | S - Sale | $92.63 | -334 | 77,518 | 0% | -$30,938 | ||||||
2026-09-16 | RVMD | Revolution Medicines, Inc. | Sandler Alan B. | Chief Development Officer | S - Sale | $199.24 | -341 | 52,868 | -1% | -$67,941 | ||||||
2026-09-16 | RVMD | Revolution Medicines, Inc. | Mancini Anthony | See Remarks | S - Sale | $199.24 | -1,774 | 42,116 | -4% | -$353,449 | ||||||
2026-09-16 | RVMD | Revolution Medicines, Inc. | Kelsey Stephen Michael | See Remarks | S - Sale | $199.24 | -5,569 | 286,307 | -2% | -$1,109,554 | ||||||
2026-09-16 | RVMD | Revolution Medicines, Inc. | Horn Margaret A | COO | S - Sale | $199.24 | -4,967 | 149,680 | -3% | -$989,613 | ||||||
2026-09-16 | RVMD | Revolution Medicines, Inc. | Goldsmith Mark A | See Remarks | S - Sale | $199.24 | -13,988 | 970,250 | -1% | -$2,786,938 | ||||||
2026-09-18 | SYNA | Synaptics Inc | Song Esther | See Remarks | S - Sale | $92.63 | -63 | 14,482 | 0% | -$5,836 | ||||||
2026-09-16 | RVMD | Revolution Medicines, Inc. | Cislini Jeff | SVP, GC | S - Sale | $199.24 | -3,366 | 52,541 | -6% | -$670,631 | ||||||
2026-09-16 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale | $199.24 | -4,053 | 119,216 | -3% | -$807,513 | ||||||
2026-09-16 | GKOS | Glaukos Corp | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | S - Sale | $166.92 | -1,457 | 72,433 | -2% | -$243,204 | ||||||
| M | 2026-09-16 | PTCT | Ptc Therapeutics, Inc. | Schmertzler Michael | Dir | S - Sale | $67.49 | -20,000 | 1,459,860 | -1% | -$1,349,728 | |||||
2026-09-17 | NVDA | Nvidia Corp | Kress Colette | EVP, CFO | S - Sale | $219.05 | -34,918 | 4,775,733 | -1% | -$7,648,632 | ||||||
2026-09-17 | BRFH | Barfresh Food Group Inc. | Roger Lisa | Former Chief Financial Officer | S - Sale | $1.10 | -25,329 | 46,414 | -35% | -$27,862 | ||||||
| M | 2026-09-16 | LITE | Lumentum Holdings Inc. | Wupen Yuen | Pres, GLOBAL BUS. UNITS | S - Sale | $903.43 | -1,500 | 111,627 | -1% | -$1,355,140 | |||||
2026-09-17 | AMBA | Ambarella Inc | Wang Feng-Ming | CEO | S - Sale | $64.83 | -6,086 | 767,759 | -1% | -$394,555 | ||||||
2026-09-17 | AMBA | Ambarella Inc | Ju Chi-Hong | SVP, Systems, GM | S - Sale | $64.83 | -2,009 | 162,153 | -1% | -$130,243 | ||||||
2026-09-17 | AMBA | Ambarella Inc | Lee Chan W | Chief Operations Officer | S - Sale | $64.83 | -2,893 | 154,443 | -2% | -$187,553 | ||||||
2026-09-17 | AMBA | Ambarella Inc | Young John Alexander | CFO | S - Sale | $64.83 | -3,126 | 109,702 | -3% | -$202,659 | ||||||
| M | 2026-09-16 | XOS | Xos, Inc. | Ostermann Dietmar | Dir | S - Sale | $2.55 | -5,000 | 85,226 | -6% | -$12,748 | |||||
| DM | 2026-09-16 | HRMY | Harmony Biosciences Holdings, Inc. | Budur Kumar | CHIEF MEDICAL OFFICER | S - Sale+OE | $43.05 | -38,452 | 13,115 | -75% | -$1,655,416 | |||||
| M | 2026-09-17 | BNTX | Biontech Se | Sahin Ugur | CEO, 10% | S - Sale | $97.49 | -64,000 | 39,707,320 | 0% | -$6,239,071 | |||||
| D | 2026-09-17 | UTHR | United Therapeutics Corp | Rothblatt Martine A | CHAIRPERSON, CEO | S - Sale+OE | $496.06 | -9,500 | 668,728 | -1% | -$4,712,580 | |||||
| D | 2026-09-17 | UTHR | United Therapeutics Corp | Mahon Paul A | EVP, GC | S - Sale+OE | $497.54 | -8,300 | 45,172 | -16% | -$4,129,608 | |||||
2026-09-17 | GFS | Globalfoundries Inc. | Azar Samak L | GC | S - Sale | $44.87 | -335 | 9,464 | -3% | -$15,031 | ||||||
| D | 2026-09-17 | DNTH | Dianthus Therapeutics, Inc. /De/ | Carr Edward | CHIEF ACCOUNTING OFFICER | S - Sale+OE | $101.38 | -20,000 | 0 | -100% | -$2,027,646 | |||||
| D | 2026-09-16 | DELL | Dell Technologies Inc. | Sl Spv-2, L.P. | Dir, 10% | S - Sale+OE | $567.88 | -46,994 | 1,903,097 | -2% | -$26,686,941 | |||||
| D | 2026-09-16 | DELL | Dell Technologies Inc. | Silver Lake Partners Iv, L.P. | Dir, 10% | S - Sale+OE | $567.89 | -56,794 | 1,903,097 | -3% | -$32,252,745 | |||||
| D | 2026-09-16 | DELL | Dell Technologies Inc. | Silver Lake Technology Investors Iv, L.P. | Dir, 10% | S - Sale+OE | $567.88 | -1,054 | 1,903,097 | 0% | -$598,549 | |||||
| M | 2026-09-16 | TELA | Tela Bio, Inc. | Capper Joseph H | Dir | P - Purchase | $1.18 | +75,000 | 179,827 | +72% | +$88,795 | |||||
| D | 2026-09-16 | DELL | Dell Technologies Inc. | Silver Lake Technology Investors V, L.P. | Dir, 10% | S - Sale+OE | $567.89 | -475 | 1,903,097 | 0% | -$269,750 | |||||
2026-09-16 | GPUS | Hyperscale Data, Inc. | Horne William B. | CEO | P - Purchase | $18.00 | +1,000 | 306,000 | 0% | +$18,000 | ||||||
| D | 2026-09-16 | DELL | Dell Technologies Inc. | Silver Lake Partners V De (Aiv), L.P. | Dir, 10% | S - Sale+OE | $567.88 | -26,985 | 1,903,097 | -1% | -$15,324,239 | |||||
2026-09-16 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | S - Sale | $25.00 | -3,674 | 112,508 | -3% | -$91,853 | ||||||
2026-09-16 | MPLT | Maplight Therapeutics, Inc. | Hanson Kristopher | GC | S - Sale | $11.67 | -16,509 | 137,044 | -11% | -$192,660 | ||||||
| D | 2026-09-17 | GNRC | Generac Holdings Inc. | Taffe Norman P | Pres Generac Home | S - Sale+OE | $229.50 | -150 | 11,276 | -1% | -$34,425 | |||||
| D | 2026-09-16 | AVTX | Avalo Therapeutics, Inc. | Sullivan Christopher Ryan | CFO | S - Sale+OE | $16.33 | -12,394 | 39,900 | -24% | -$202,437 | |||||
| D | 2026-09-17 | GNRC | Generac Holdings Inc. | Raabe Kyle Andrew | Pres, Home Power Gen. | S - Sale+OE | $229.50 | -603 | 10,356 | -6% | -$138,389 | |||||
2026-09-17 | QUIK | Quicklogic Corp | Nader Elias | CFO, SVP Finance | S - Sale | $10.21 | -8,291 | 88,845 | -9% | -$84,680 | ||||||
2026-09-17 | QUIK | Quicklogic Corp | Faith Brian C | Pres, CEO | S - Sale | $10.21 | -17,255 | 271,065 | -6% | -$176,234 | ||||||
| D | 2026-09-16 | PVLA | Palvella Therapeutics, Inc. | Goin Kathleen | COO | S - Sale+OE | $152.24 | -4,302 | 0 | -100% | -$654,923 | |||||
2026-09-17 | QUIK | Quicklogic Corp | Saxe Timothy | SVP, CTO | S - Sale | $10.21 | -10,364 | 152,214 | -6% | -$105,853 | ||||||
2026-09-16 | RVTY | Revvity, Inc. | Vohra Tajinder S | Please See Remarks | S - Sale | $140.88 | -7,330 | 6,635 | -52% | -$1,032,650 | ||||||
2026-09-16 | CBIO | Crescent Biopharma, Inc. | Lynch Ryan | See Remarks | S - Sale | $17.90 | -240 | 13,631 | -2% | -$4,296 | ||||||
2026-09-16 | CBIO | Crescent Biopharma, Inc. | Pinkas Jan | Chief Scientific Officer | S - Sale | $17.90 | -658 | 21,581 | -3% | -$11,778 | ||||||
2026-09-16 | CBIO | Crescent Biopharma, Inc. | Im Ellie Eunkyung | Chief Medical Officer | S - Sale | $17.90 | -623 | 21,446 | -3% | -$11,152 | ||||||
2026-09-16 | CBIO | Crescent Biopharma, Inc. | Scalzo Richard William | CFO | S - Sale | $17.90 | -568 | 19,730 | -3% | -$10,167 | ||||||
| M | 2026-09-16 | PRLB | Proto Labs Inc | Schumacher Daniel | CFO | S - Sale | $85.21 | -5,000 | 40,019 | -11% | -$426,035 | |||||
2026-09-16 | CBIO | Crescent Biopharma, Inc. | Bispham Barbara Harlin | See Remarks | S - Sale | $17.90 | -620 | 18,710 | -3% | -$11,098 | ||||||
| M | 2026-09-16 | CBIO | Crescent Biopharma, Inc. | Brumm Joshua T | CEO | S - Sale | $16.91 | -9,447 | 271,765 | -3% | -$159,775 | |||||
| M | 2026-09-16 | CBIO | Crescent Biopharma, Inc. | McNeill Jonathan | Pres, COO | S - Sale | $16.90 | -4,570 | 134,588 | -3% | -$77,235 | |||||
2026-09-16 | SMTC | Semtech Corp | Cardenuto Rodolpho C | Dir | S - Sale | $165.00 | -5,321 | 0 | -100% | -$877,978 | ||||||
2026-09-17 | TER | Teradyne, Inc | Matz Marilyn | Dir | S - Sale | $351.11 | -400 | 13,841 | -3% | -$140,444 | ||||||
2026-09-16 | BLBD | Blue Bird Corp | Sanfrey Jeffrey Scott | COO | S - Sale | $62.40 | -4,000 | 35,011 | -10% | -$249,600 | ||||||
2026-09-16 | SONY | Sony Group Corp | Ito Yasuhiro | Chief People Officer (CPO) | S - Sale | $24.29 | -9,000 | 6,489 | -58% | -$218,610 | ||||||
| A | 2026-09-11 | ECOR | Electrocore, Inc. | Fox Michael | See Remarks | P - Purchase | $9.80 | +5,000 | 130,000 | +4% | +$49,004 | |||||
2026-09-17 | AIM | Aim Immunotech Inc. | Equels Thomas K | CEO, Pres | P - Purchase | $0.21 | +24,000 | 126,822 | +23% | +$4,992 | ||||||
2026-09-16 | KRMN | Karman Holdings Inc. | Stinnett David | Dir | P - Purchase | $37.32 | +27,000 | 3,530,395 | +1% | +$1,007,648 | ||||||
2026-09-16 | KRMN | Karman Holdings Inc. | Petryszyn Mary D | Dir | P - Purchase | $37.44 | +500 | 2,863 | +21% | +$18,720 | ||||||
2026-09-16 | KRMN | Karman Holdings Inc. | Twitty Stephen | Dir | P - Purchase | $36.79 | +275 | 2,638 | +12% | +$10,117 | ||||||
| DM | 2026-09-15 | TVTX | Travere Therapeutics, Inc. | Rote William E. | Chief Research Officer | S - Sale+OE | $62.83 | -209,048 | 98,197 | -68% | -$13,135,397 | |||||
| DM | 2026-09-15 | TVTX | Travere Therapeutics, Inc. | Heerma Peter | EVP, CHIEF COMMERCIAL OFFICER | S - Sale+OE | $63.06 | -283,189 | 117,066 | -71% | -$17,857,830 | |||||
| D | 2026-09-15 | TVTX | Travere Therapeutics, Inc. | Inrig Jula | EVP, Head of R, D, CMO | S - Sale+OE | $62.34 | -44,674 | 100,491 | -31% | -$2,785,021 | |||||
| D | 2026-09-15 | TVTX | Travere Therapeutics, Inc. | Reed Elizabeth E | GC, GC | S - Sale+OE | $62.34 | -37,500 | 105,389 | -26% | -$2,337,695 | |||||
| DM | 2026-09-15 | TVTX | Travere Therapeutics, Inc. | Dube Eric M | CEO | S - Sale+OE | $63.48 | -400,000 | 432,886 | -48% | -$25,390,729 | |||||
| D | 2026-09-15 | TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CFO | S - Sale+OE | $62.34 | -50,508 | 87,508 | -37% | -$3,148,544 | |||||
| D | 2026-09-16 | TENX | Tenax Therapeutics, Inc. | Doogan Declan | Dir | P - Purchase | $1.92 | +53,000 | 55,274 | >999% | +$101,760 | |||||
| D | 2026-09-15 | TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | S - Sale+OE | $62.33 | -5,375 | 42,353 | -11% | -$335,005 | |||||
2026-09-15 | CBLL | Ceribell, Inc. | Chao Xingjuan | Pres, CEO | S - Sale | $25.03 | -20,846 | 1,115,433 | -2% | -$521,775 | ||||||
| D | 2026-09-15 | CBLL | Ceribell, Inc. | Blumberg Scott | CFO | S - Sale+OE | $25.00 | -846 | 146,600 | -1% | -$21,150 | |||||
2026-09-03 | NN | Nextnav Inc. | Sorond Mariam | CEO, Pres, Dir | S - Sale | $14.72 | -2,831 | 1,168,961 | 0% | -$41,663 | ||||||
2025-09-15 | COHU | Cohu Inc | Bohrson Christopher | Chief Recurring Officer | S - Sale | $51.07 | -1,000 | 158,702 | -1% | -$51,070 | ||||||
2026-09-15 | KTOS | Kratos Defense & Security Solutions, Inc. | Mendoza Marie | SVP, GC | S - Sale | $48.50 | -1,000 | 61,200 | -2% | -$48,500 | ||||||
2026-09-15 | KTOS | Kratos Defense & Security Solutions, Inc. | Carrai Phillip D | Pres, STC Division | S - Sale | $47.83 | -6,500 | 222,297 | -3% | -$310,901 | ||||||
2026-09-16 | FORM | Formfactor Inc | Slessor Mike | CEO | S - Sale | $104.73 | -17,510 | 466,694 | -4% | -$1,833,817 | ||||||
2026-09-15 | ADPT | Adaptive Biotechnologies Corp | Bobulsky Susan | Chief Commercial Officer, MRD | S - Sale | $27.00 | -1,195 | 395,794 | 0% | -$32,265 | ||||||
2026-09-17 | CGC | Canopy Growth Corp | Stewart Thomas Carlton | See Remarks | S - Sale | $0.93 | -25,755 | 588,412 | -4% | -$23,952 | ||||||
2026-09-15 | ROIV | Roivant Sciences Ltd. | Epperly Melissa B, | Dir | S - Sale | $39.74 | -4,938 | 9,900 | -33% | -$196,230 | ||||||
2026-09-15 | ROIV | Roivant Sciences Ltd. | Fitzgerald Meghan | Dir | S - Sale | $39.74 | -5,112 | 36,108 | -12% | -$203,152 | ||||||
| D | 2026-09-15 | AAPL | Apple Inc. | Newstead Jennifer | SVP, GC, Government Affairs | S - Sale+OE | $330.19 | -1,438 | 46,790 | -3% | -$474,813 | |||||
2026-09-17 | PL | Planet Labs Pbc | Johnson Ashley F. | Pres, CFO | S - Sale | $16.96 | -55,663 | 1,555,585 | -3% | -$944,312 | ||||||
| D | 2026-09-16 | AMPH | Amphastar Pharmaceuticals, Inc. | Zhou Rong | SENIOR EVP, PRODUCTION CENTER | S - Sale+OE | $23.94 | -10,000 | 273,871 | -4% | -$239,404 | |||||
| M | 2026-09-15 | PBI | Pitney Bowes Inc /De/ | Wolf Kurt James | Pres, CEO | S - Sale | $17.34 | -199,258 | 2,735,950 | -7% | -$3,455,342 | |||||
2026-09-17 | PL | Planet Labs Pbc | Schingler Robert H | Co-Founder Chief Strategy Offi | S - Sale | $16.96 | -52,240 | 889,355 | -6% | -$886,225 | ||||||
| D | 2026-09-15 | DELL | Dell Technologies Inc. | Silver Lake Technology Investors V, L.P. | Dir, 10% | S - Sale+OE | $552.79 | -476 | 1,853,829 | 0% | -$263,126 | |||||
| M | 2026-09-15 | CRCT | Cricut, Inc. | Ashish Arora | CEO, 10% | S - Sale | $5.62 | -180,000 | 5,417,105 | -3% | -$1,011,150 | |||||
| D | 2026-09-15 | INDI | Indie Semiconductor, Inc. | McClymont Donald | CEO | S - Sale+OE | $3.11 | -50,000 | 5,365,566 | -1% | -$155,460 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |